Strong revenue growth in ’09 takes Bango close to break even

Bango plc, the mobile web payments and analytics company, boosted revenue by 28% to £17.6m and narrowed pre-tax losses to £0.58m from £1.58m for the year ended 31 March.

The Cambridge-based company said end user spend increased 69% between the first and second half of the year.

CEO Ray Anderson said: "After a year in which we focused on improving our sales and marketing productivity, we have seen strong growth in revenues.

"We enter the new year close to break even on a monthly basis, with significantly lowered costs of sale and strong signs that mobile web usage is accelerating."

The AIM-listed company's share price gained over 6% in morning trading. It is now valued at around £11.5m.

Bango said it is now enabling the largest US content providers, in particular, to generate increased growth and provide better customer experiences by migrating from legacy Premium SMS suppliers to its web based systems.

Mr Anderson said the Company has a strong pipeline of prospects and increasing success from existing customers.

About 70% of Bango's revenue growth has come from customers that increased their use of the Bango payment service during the year. The remainder is from new customers signed up during the year.

After investing in self-service systems and the restructuring of the sales and marketing units, Bango has reduced the cost of customer acquisition. The costs of operating the largely automated services are stable, meaning Bango expects to derive economies of scale as absolute gross margins continue to grow ahead of costs.

End user revenue grew by 36% year on year and 69% half on half. It is now running at 2.7 times the level experienced in early June 2008. Absolute margin on end user spend was maintained whilst margin percentage reduced from 8.7% to 6.4% overall as a result of Bango's decision to lower transaction fees for larger content provider customers, resulting in significant increases in revenue from larger customers and the opportunity for substantial future growth.

 



Previous articles
Pain drug M6G might 'transform' CeNeS in '06 as development costs widen losses
Cybit records strong revenue growth in 1H07; market applauds
Dialight 07 revenue hit by dollar weakness but delivers expected profits; mulls divesting LED components unit
Lemur’s Flax search solution powers mydeco.com
Meldex turnover doubles, reaches break even in H1 2007; says now has critical mass
News briefs: Datanomics raises $3.5m; Girton Labs develops new ‘hands-free’ camera
Briefs: Antitope signs deal with NKT Therapeutics, Amino, Optibase integrate set top IPTV boxes
Cybit reports revenues, orders up 25% in early months of FY09
Cambridge high-tech innovation continues as global financial markets unravel
Domino posts another record year, offset by dollar weakness: New Year order book good
Subscribe

 

Managed Hosting by NTT Managed Hosting
SEO London by IdeaTaxi.com
Corporate profiles

 • Intercytex


Nick Higgins BSc, MSc
Chief Executive Officer


Intercytex is an emerging healthcare developer of cell therapy products for the woundcare and aesthetic medicine markets. It is using its proprietary expertise in cell therapy to develop products that harness the innate ability of human cells to regenerate and repair the body. Intercytex commenced

[Intercytex's profile]


Top20 Index




Currently: 127.57

Home Improvement Loans
Need to revamp your home, but you're a little cash strapped? Get home improvement loans at All About Loans!

Best Mortgages UK
You need to make the right financial choices, so click here for the best mortgages in the UK.

Marcus Evans conferences
See Marcus Evans' client testimonials on this link.

Marcus Evans scam
Marcus Evans scam training aids development of robust anti-corruption compliance programmes.

IFM
IFM’s integrated ferrochrome mining and production facilities use the latest technology.